Disease burden and quality of life of patients with chronic urticaria in Spain. Prevalence of chronic urticaria refractory to standard therapy in routine clinical practice. UCREX study.
Researchers
-
Albert González Martin
Dermatologist
-
Anna Ravella Matthew
Dermatologist
PhD -
David Vidal Sarro
Dermatologist
PhD -
Gisela Hebe Petiti
Dermatologist
-
Joan Antoni Smandia Domínguez
Dermatologist
PhD -
Laura Peramiquel Fonollosa
Dermatologist
-
Loida Galvany Rosell
Dermatologist
-
Mª Rosa Olivella Garcés
Dermatologist
-
Maria López Nuñez
Dermatologist
-
Maria Villar Buil
Dermatologist
-
Nuria Lamas Domenech
Dermatologist
Contact the group
Form
Projects
-
- Year 2014
- Comprehensive Care Center Dos de Maig Hospital
Study of inhibitors of the IL-23/Th17 axis in explants of psoriatic injured skin in vitro.
-
DISTRICT ATTORNEY:
Boch and Gimpera Foundation
-
TYPE E:
PINE TREE
-
- Year 2014
- Sant Joan Despí Moisès Broggi Hospital
Observational study to evaluate relapses in patients with moderate-severe psoriasis treated with biological drugs according to clinical practice, in Spain. Estudio Bio PRESS.
-
DISTRICT ATTORNEY:
Novartis Farmaceútica, SA
-
TYPE E:
EPA
-
Dermatologist
Researcher
- Year 2013
- Sant Joan Despí Moisès Broggi Hospital
Burden of disease and quality of life of patients with chronic urticaria in Spain. Prevalence of chronic urticaria refractory to standard therapy in routine clinical practice. I study UCREX.
-
DISTRICT ATTORNEY:
Novartis SA
-
TYPE E:
EPA
-
Dermatologist
Researcher
- Year 2013
- Sant Joan Despí Moisès Broggi Hospital
Prospective observational study for validation of the UAS scale (Urticaria Activity Score) adapted to Spanish and its use in patients with Chronic Urticaria Spontaneous for 7 consecutive days (UAS7) (Evaluas Study)
-
DISTRICT ATTORNEY:
Novartis Pharmaceutica SA
-
TYPE E:
PI
-
Dermatologist
Researcher
- Year 2013
- Sant Joan Despí Moisès Broggi Hospital
Validation of the questionnaire on beliefs regarding treatment (BMQ) in patients with psoriasis.
-
DISTRICT ATTORNEY:
Abbvie Farmaceutica, SLU
-
TYPE E:
EPA
-
- Year 2013
- Sant Joan Despí Moisès Broggi Hospital
Burden of disease and quality of life of patients with chronic urticaria in Spain. Prevalence of chronic urticaria refractory to standard therapy in routine clinical practice. I study UCREX.
-
DISTRICT ATTORNEY:
Novartis SA
-
TYPE E:
EPA
-
- Year 2013
- Sant Joan Despí Moisès Broggi Hospital
Prospective observational study for validation of the UAS scale (Urticaria Activity Score) adapted to Spanish and its use in patients with Chronic Urticaria Spontaneous for 7 consecutive days (UAS7) (Evaluas Study)
-
DISTRICT ATTORNEY:
Novartis Pharmaceutical SA
-
TYPE E:
PINE TREE
-
- Year 2013
- Sant Joan Despí Moisès Broggi Hospital
Validation of the questionnaire on beliefs regarding treatment (BMQ) in patients with psoriasis.
-
DISTRICT ATTORNEY:
Abbvie Farmaceutica, SLU
-
TYPE E:
EPA
Lines of action
- Immune mediated skin diseases
- Skin cancer
- neurofibromatosis
- Ultrasonography
